BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38431660)

  • 1. The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.
    Liu B; Liu XY; Wang GP; Chen YX
    Sci Rep; 2024 Mar; 14(1):5184. PubMed ID: 38431660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
    Hong X; Fu R
    PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
    Xie L; Zeng J; He M
    BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
    Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
    Front Immunol; 2022; 13():992266. PubMed ID: 36405691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
    Xu F; Yan J; Peng Z; Liu J; Li Z
    Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two immune subtypes in osteosarcoma based on immune gene sets.
    Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z
    Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma.
    Wang Q; Zhang W; Guo Y; Li Y; Fu K
    Aging (Albany NY); 2021 Nov; 13(21):24155-24170. PubMed ID: 34747719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
    Zhang X; Wen Z; Wang Q; Ren L; Zhao S
    Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
    Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
    Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
    Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
    J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
    Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma.
    Chen S; Zeng J; Huang L; Peng Y; Yan Z; Zhang A; Zhao X; Li J; Zhou Z; Wang S; Jing S; Hu M; Li Y; Wang D; Wang W; Yu H; Miao J; Li J; Deng Y; Li Y; Liu T; Xu D
    J Transl Med; 2022 May; 20(1):228. PubMed ID: 35568866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
    Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
    Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
    Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
    Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
    Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Defined Necroptosis-Related Genes Prognostic Signature for Predicting Prognosis and Treatment of Osteosarcoma.
    Zhao S; Wang T; Huang F; Zhao Q; Gong D; Liu J; Yi C; Liang S; Bian E; Tian D; Jing J
    Biochem Genet; 2024 Apr; 62(2):831-852. PubMed ID: 37460861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New gene signature from the dominant infiltration immune cell type in osteosarcoma predicts overall survival.
    Gong L; Sun X; Jia M
    Sci Rep; 2023 Oct; 13(1):18271. PubMed ID: 37880378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.